The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer

The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer

Saved in:
Bibliographic Details
Published in:Value in health Vol. 17; no. 7; p. A642
Main Authors: Djalalov, S, Graham, D.M, Beca, J, Hoch, J.S, Tsao, M.S, Leighl, N
Format: Journal Article
Language:English
Published: United States 01-11-2014
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2014.08.2321